Model Number SN60T3 |
Device Problem
Material Opacification (1426)
|
Patient Problem
Visual Disturbances (2140)
|
Event Date 02/09/2018 |
Event Type
Injury
|
Event Description
|
A health care professional reported that approximately nine years following a cataract removal with intraocular lens (iol) implant procedure, the iol was observed to be opaque.There was no reported harm to the patient.The patient will return for re-evaluation in three to four months.Additional information has been received and stated that there was reduction in patients quality of vision.The surgeon iol exchange would be beneficial to the patient but not yet explanted at the time of reporting.
|
|
Manufacturer Narrative
|
This product malfunction was originally reported under an alternative summary report.Additional information has been has been provided which prompts a different assessment.As the alternative summary report has been revoked, the updated information is being sent via this 3500a report.The product was not returned.Product history records were reviewed and the documentation indicated the product met release criteria.Root cause has not been identified.There are no other complaints in this lot.The manufacturer internal reference number is: (b)(4).
|
|
Manufacturer Narrative
|
The lens was retuned on a peel sticker, inside a small specimen cup.Blood was dried on the lens.One haptic was broken in the gusset area (not returned).The optic was torn/split/cracked and cut into pieces, typical of insertion and removal.The lens was cleaned with klrp (klotho-related protein) for further evaluation.The lens appears clear.Power and resolution testing could not be conducted due to the extensive optic damage.The product investigation could not identify a root cause for the reported complaint.The power and resolution of each lens is 100% evaluated during the manufacturing process to determine acceptability per model and diopter.The manufacturer internal reference number is: (b)(4).
|
|
Event Description
|
Additional information received and stated that, the iol was explanted in a secondary procedure.
|
|
Search Alerts/Recalls
|